Ordenar

Buscar

17/02/2026 Long-term response Patterns in HER2-positive advanced breast cancer within the geicam/2014-03 (registem) study
Alvarez, I, Guerrero-Zotano, A, Cruz-Jurado, J, Antol n, S, Galve, E, Rodr guez, C, Hern ndez, M, Tibau, A, Falo, C, Chac n, J, Miguel, A, Rodr guez-Lescure, A, Adrover, E, Margel -Vila, M, Andr s, R, Servitja, S, Merino, M, Gonz lez, I, Alonso-Romero, J, Villanueva, R, Echarri, M, Ant n-Torres, A, Varela, S, Ru z-Borrego, M, Guerra, J, Corbellas, M, Escudero, M, Bezares, S, Rojo, F, L pez-Tarruella, S. Long-term response Patterns in HER2-positive advanced breast cancer within the geicam/2014-03 (registem) study. CLINICAL CANCER RESEARCH. 2026; 32DOI:. PMID:. IF:10.200(Q1/1D).
17/02/2026 A Dive into the Invisible: The Vaginal and Endometrial Microbiota in Gynecologic and Obstetric Disorders: A Narrative Review
Schettini, G, Pieri, E, Rizzo, C, Giorgi, M, Mancini, V, Habib, N, Rovira, R, Centini, G. A Dive into the Invisible: The Vaginal and Endometrial Microbiota in Gynecologic and Obstetric Disorders: A Narrative Review. Life-Basel. 2026; 16(2)DOI:10.3390/life16020344. PMID:41752979. IF:3.400(Q1/3D).
15/02/2026 TRI•Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repair
Sisinni, A, Barreiro-Perez, M, Freixa, X, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, MN, Nombela-Francoi, L, Pascual, I, Benito-González, T, Perez, R, Gomez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Sanchis, L, Echarte-Morales, J, Li, CH, del Trigo, M, Martínez-Carmona, JD, Mesa, D, Pozo, E, Avanzas, P, Cepas-Guillén, P, Estévez-Loureiro, R. TRI•Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repair. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2026; 445DOI:10.1016/j.ijcard.2025.134021. PMID:41271020. IF:3.200(Q2/3D).
15/02/2026 Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials
Escrihuela-Vidal, F, Ong, SWX, Oriol, I, Grillo, S, Pujol, M, Pallarès, N, Tebé, C, Liu, K, Miro, JM, Tong, SYC, Carratalà, J. Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials. CLINICAL INFECTIOUS DISEASES. 2026; 82(2)DOI:10.1093/cid/ciaf387. PMID:40670317. IF:7.300(Q1/1D).
14/02/2026 Unravelling the activity rhythms of urban vector mosquitoes with smart-trap technology
González-Pérez, MI, Cerecedo-Iglesias, C, Richter-Boix, A, Barahona, L, Montalvo, T, Palmer, JRB, Bartumeus, F. Unravelling the activity rhythms of urban vector mosquitoes with smart-trap technology. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-026-38795-y. PMID:41691036. IF:3.900(Q1/2D).
12/02/2026 Effectiveness, acceptability and oral health-related quality of life of silver diamine fluoride compared with atraumatic restorative treatment for the management of early childhood caries: protocol of a pragmatic randomised clinical trial
Millán, PM, Pineda, P, Fontana, M, Freyhofer, VA, Ormeño, A, Muñoz, K, Martinez-Zapata, MJ, Zaror, C. Effectiveness, acceptability and oral health-related quality of life of silver diamine fluoride compared with atraumatic restorative treatment for the management of early childhood caries: protocol of a pragmatic randomised clinical trial. BMJ Open. 2026; 16(2)DOI:10.1136/bmjopen-2025-106271. PMID:41688106. IF:2.300(Q2/3D).
10/02/2026 A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin
Rovira, I, Montemayor, E, Gil-Alonso, S, Miranda-Cadena, K, Sanchez-Reus, F, Quindos, G, Eraso, E, Jauregizar, N. A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin. ACS Omega. 2026; 11(5)DOI:10.1021/acsomega.5c10111. PMID:41696345. IF:4.300(Q2/4D).
10/02/2026 Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein
Alamo, P, López-Laguna, H, Favaro, MTP, Gallardo, A, Alba-Castellon, L, Villaverde, A, Mangues, R, Vázquez, E. Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein. INTERNATIONAL JOURNAL OF PHARMACEUTICS. 2026; 690DOI:10.1016/j.ijpharm.2026.126585. PMID:41521013. IF:5.200(Q1/2D).